Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis

Rift Valley fever (RVF) is an emerging arboviral disease affecting both humans and livestock. In humans, RVF displays a spectrum of clinical manifestations, including encephalitis. To date, there are no FDA-approved vaccines or therapeutics for human use, although several are in preclinical developm...

Full description

Bibliographic Details

Published in:	JCI Insight
Main Authors:	Kaleigh A. Connors, Nathaniel S. Chapman, Cynthia M. McMillen, Ryan M. Hoehl, Jackson J. McGaughey, Zachary D. Frey, Morgan Midgett, Connor Williams, Douglas S. Reed, James E. Crowe Jr., Amy L. Hartman
Format:	Article
Language:	English
Published:	American Society for Clinical investigation 2024-09-01
Subjects:	Immunology Infectious disease
Online Access:	https://doi.org/10.1172/jci.insight.180151